News | February 04, 2022
Sputnik V vaccine granted full approval in Russia
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
It would be the first protein-based alternative available in Israel
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The vaccines are currently only authorised for emergency use in the country
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials
Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
